| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -6.4 | 0.5 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -5.3 | 0.6 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.35 | 0.01 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.31 | 0.05 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.24 | 0.2 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.24 | 0.2 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.23 | 0.1 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.23 | 0.1 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.2 | 0.3 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.18 | 0.0006 |